Clinical Validation of Cervical Cancer Screening Methods

Last updated: March 2, 2021
Sponsor: N.N. Petrov National Medical Research Center of Oncology
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cervical Intraepithelial Neoplasia

Cervical Dysplasia

Dysfunctional Uterine Bleeding

Treatment

N/A

Clinical Study ID

NCT04783649
CC-001
  • Ages 25-65
  • Female
  • Accepts Healthy Volunteers

Study Summary

This single-institution cross-sectional non-inferiority validation study evaluates alternative techniques and tests for primary cervical cancer screening programs in Russia, particularly: local cytology staining techniques, local HPV tests.

Eligibility Criteria

Inclusion

Inclusion Criteria: Age between 25 and 65 years old Referral to colposcopy or to a primary screening testSigned informed consent

Exclusion

Exclusion Criteria: Prior history of malignancy or cervical dysplasia Prior history of cervical dysplasia

Study Design

Total Participants: 2500
Study Start date:
July 13, 2020
Estimated Completion Date:
July 01, 2023

Study Description

Cervical cytology practices are different across the world. While the Pap test became the cornerstone of the highly-effective cervical cancer screening in the countries that initially implemented population-based programs in the 60s and the 70s, alternative staining techniques were implemented in the Soviet Union. The tradition to apply other staining techniques than conventional Pap test remained unchanged in the national screening program implemented in the 2010s in Russia. As a new alternative option HPV testing showed effectiveness in screening women older than 30. The acceptable sensitivity and specificity of a screening test are crucial in population-based screening, that is why validation against "the gold standard" should be the first step in the process of program implementation. The objective of this study is to evaluate alternative techniques and tests for primary cervical cancer screening programs in Russia, particularly: local cytology staining techniques, local HPV tests in the population of 25-65 yo women without prior history of malignancy referred to colposcopy enriched with a population sample of women from several primary healthcare facilities referred to a primary screening test.

Connect with a study center

  • N.N. Petrov National Medical Research Center of Oncology

    Saint Petersburg, 197758
    Russian Federation

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.